Moving xenotransplantation research into human trials will require adjusting our expectations, researchers say

Loading

On the heels of some important “firsts” this past year, xenotransplantation — grafting animal organs into humans — is on the cusp of crossing over into new territory: human trials.

In January, University of Maryland surgeons transplanted a pig heart into a 57-year-old man, who survived two months. And last fall, New York University doctors implanted pig kidneys into recently deceased individuals to show there wouldn’t be immediate rejection of the organs. As exciting as these procedures were for researchers who have been trying to make xenotransplantation a reality, they highlighted the slow pace of clinical development, which has been stalled in primate studies for decades. Read more.

Loading

Researchers use CareDx solutions to monitor first successful heart xenotransplantation

Loading

CareDx Inc. announced its non-invasive organ transplant surveillance solutions were used to monitor postoperative graft health in the first successful heart xenotransplantation.

According to the press release, surgeons from the University of Maryland School of Medicine (UMSOM) are using versions of two Care-Dx surveillance solutions to monitor the genetically modified pig heart they transplanted into a patient on Jan. 7, 2022. Read more.

Loading